The SyncroPatch 384 is installed at the FDA for cardiac safety pharmacology studies
Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (…
Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (…
EBAMed SA, an early-stage medical device company pioneering new approaches to proton therapy today announced the enrollm…
EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experience…
OneProjects Ltd, an Irish-German medical device start-up specialising in cardiac imaging innovations, today announced th…
April 17th 2020: Nanion Technologies GmbH, a leading provider of automated patch clamp and cell monitoring systems, anno…
Nanion Technologies, a leading provider of automated electrophysiology systems, today announced the partnership with Ass…
Transporter proteins are gaining increasing interest in academic science and as therapeutic targets. Nanion’s two platfo…
Reisekrankheiten wie Übelkeit oder Durchfall entstehen häufig dann, wenn unser Organismus mit Bakterien in Kontakt kommt…
Remote Magnetic Catheter Systems has been manufactured in such a manner that enhance patient care in atrial arrhythmia d…
The European Heart Rhythm Association (EHRA) released the analytical supplement to the 10th EHRA White Book during the E…